Evidence map›Paper›PMID 40951606›Full record

ArticleJournal of the colleges of medicine of South Africa2025

Utility of shock index to predict mortality risk in decompensated heart failure.

Amanda Naidoo-Pillay, Suma Rajan, Andreas Engelbrecht

Abstract read
In one paragraph

Article in Journal of the colleges of medicine of South Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amanda Naidoo-PillayDivision of Emergency Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0009-0005-3854-6548
Suma RajanDivision of Emergency Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0000-0002-3452-3163
Andreas EngelbrechtDivision of Emergency Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.ORCID https://orcid.org/0000-0001-9846-189X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Decompensated heart failure (HF) is a serious condition that requires rapid evaluation and treatment. Shock index (SI) is a bedside predictor tool used to identify risk of mortality and morbidity. Methods: This multicentre retrospective descriptive study evaluated SI, modified shock index (MSI) and reverse shock index (RSI) as predictors of mortality in decompensated HF. Emergency department records for a 6-month period were analysed. The primary outcome was to identify if SI > 0.9 could predict mortality during hospital admission. Secondary outcomes included SI > 0.9, MSI > 0.93 and RSI < 1 for prediction of 72-h mortality, use of non-invasive positive pressure ventilation, inotropic, vasopressor or nitroglycerine infusions and need for endotracheal intubation. Results: Overall mortality during hospital admission was 4.3%, impacting internal validity. For inotrope use, SI > 0.9 at 12 h produced an odds ratio (OR) of 12.33 (confidence interval [CI] 2.03-74.89; Conclusion: SI > 0.9 at 12 h predicted an increased need for inotropes. Reverse shock index demonstrates significant predictive value for mortality and critical interventions in decompensated HF. Reverse shock index appears to be the most effective index in predicting both mortality and need for critical interventions, outperforming SI and MSI. Further prospective studies are needed to validate these findings. Contribution: This research will assist with early triage of decompensated HF patients to appropriate dispositions and guide inexperienced clinicians to identify high-risk patients.

Indexed as

inotropesmodified shock indexmortalityreverse shock indexshock indexsymptomatic heart failure

Identifiers

PMID40951606
PMCPMC12424009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.